Brief: Orgenesis Announces Use Of The Tissue Genesis Icellator® In A Hospital For Special Surgery Clinical Study For Rotator Cuff Repair
10/06/2021 12:20
June 10 (Reuters) - Orgenesis Inc ORGS.O :
* ORGENESIS ANNOUNCES USE OF THE TISSUE GENESIS ICELLATOR®
IN A
HOSPITAL FOR SPECIAL SURGERY CLINICAL STUDY FOR ROTATOR CUFF
REPAIR
Source text for Eikon: ID:nGNXbd6Dh1
Further company coverage: ORGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules